TRPV1 antagonists: the challenges for therapeutic targeting
about
TRP channels in neurogastroenterology: opportunities for therapeutic interventionThe involvement of TRPV1 in emesis and anti-emesisTRP channels and temperature in airway disease-clinical significanceTRPV1 Channel: A Potential Drug Target for Treating EpilepsyUse of Capsaicin to Treat Pain: Mechanistic and Therapeutic ConsiderationsTargeting TRPV1 as an alternative approach to narcotic analgesics to treat chronic pain conditions.The endocannabinoid/endovanilloid system and depression.Different desensitization patterns for sensory and vascular TRPV1 populations in the rat: expression, localization and functional consequences.Heterotopic ossification has some nerveStructure-activity relationships of vanilloid receptor agonists for arteriolar TRPV1Constrained TRPV1 agonists synthesized via silver-mediated intramolecular azo-methine ylide cycloaddition of α-iminoamides.Antinociception of petroleum ether fraction derived from crude methanol extract of Melastoma malabathricum leaves and its possible mechanisms of action in animal models.Pharmacogenetics of chronic pain and its treatment.TRPV1 gates tissue access and sustains pathogenicity in autoimmune encephalitis.Targeting Pain-evoking Transient Receptor Potential Channels for the Treatment of Pain.The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not.Kunitz-Type Peptide HCRG21 from the Sea Anemone Heteractis crispa Is a Full Antagonist of the TRPV1 Receptor.Multi-Functional Diarylurea Small Molecule Inhibitors of TRPV1 with Therapeutic Potential for Neuroinflammation.Topical capsaicin. The fire of a 'hot' medicine is reignited.Transient receptor potential vanilloid-1 antagonists: a survey of recent patent literature.The medical treatment of overactive bladder, including current and future treatments.Current and emerging "at-site" pain medications: a reviewTransient receptor potential channels in bladder function.New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view.Calcium-permeable ion channels in pain signaling.Zucapsaicin for the treatment of neuropathic pain.Lessons from black pepper: piperine and derivatives thereof.Potential Future Pharmacological Treatment of Bladder Dysfunction.Sensory nerve induced inflammation contributes to heterotopic ossificationThe chimeric approach reveals that differences in the TRPV1 pore domain determine species-specific sensitivity to block of heat activation.Short Report: TRPV1-polymorphism 1911 A>G alters capsaicin-induced sensory changes in healthy subjectsAntinociceptive Activity of Methanol Extract of Muntingia calabura Leaves and the Mechanisms of Action Involved.Redox modulation of Ecto-NOX1 in human platelets.Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis.TRPV4 as a target for bladder overactivity.Animal Toxins Providing Insights into TRPV1 Activation Mechanism.Is heterotopic ossification getting nervous?: The role of the peripheral nervous system in heterotopic ossification.Topical delivery of TRPsiRNA-loaded solid lipid nanoparticles confer reduced pain sensation via TRPV1 silencing, in rats.Antinociceptive activity of a synthetic oxopyrrolidine-based compound, ASH21374, and determination of its possible mechanisms.The validation of Calophyllum brasiliense ("guanandi") uses in Brazilian traditional medicine as analgesic by in vivo antinociceptive evaluation and its chemical analysis.
P2860
Q24618774-1FB6C52A-22B1-4CC5-A860-40FE651A3244Q26745801-799D4242-F233-4D59-921A-EF25BCB5B607Q26745820-B6058272-E8A0-4C19-8DB9-A3DD84C7FAF1Q26786478-BBCD79A8-F929-422C-87F0-A7B255B2ED04Q28073741-DD6DDD31-5CBE-4B36-B2E1-89D071ADB9C7Q33954651-55085682-054E-4294-8619-0F0457B8BA22Q34567576-F5CBBB16-9801-483D-8BB3-4583D2ACD46CQ35046569-7F7A5C04-43BD-4D4C-8B70-729344923501Q35951629-3456D849-172D-4FFA-A977-F4B0CCFBECAFQ36025357-E9AAD65B-8B9D-4760-8059-56290A5FEC90Q36057551-3B298DE2-5310-4115-8B82-FF7EBA225F53Q36207122-A988B294-6AFF-4D0E-A9CD-4B96EAC7D070Q36900075-B4D742EA-EF99-4487-9E86-AD5DC5A45A61Q37100271-A4A8988F-17F1-4E86-A0D3-596AC4619D89Q37362053-447AEDD7-BBA0-4362-A752-91CE305E7AACQ37391727-8338E848-81D3-4CC1-BED8-72CDDBB62941Q37539438-2D58FCC1-A5F6-40B7-9689-20A2E5021BECQ37676906-5FE7177E-18D6-42D0-9F69-99AFE0D03A25Q37743506-32D41C9A-EC0D-4C77-8D17-756F64DAC298Q37768452-CC4B4762-0BE3-4082-BE04-656BB04542A9Q37836943-ACD3E519-82C7-4DE6-914A-69F0EFF39A6FQ37937444-D3C8B996-3A60-4A03-810F-213A377501E2Q38056773-9C561DF0-B2DB-4899-A068-883D71B64208Q38167283-076C28CF-A87B-4285-BFBF-F4DC1F405EF7Q38175134-D6AFB0E6-4FA9-40C7-91BB-B2F04D8BA398Q38244583-3670D0A6-C2E1-4EB2-9EA3-D25D4CEF96A6Q38631441-30DEBF10-0125-403A-A870-28D0027545B4Q38779624-2C0D8690-6423-4FBA-8FCD-AC7CBBA4711CQ39523572-0E81CFD1-C28A-4BD9-8234-51157C22A710Q39707700-286F56C7-28CE-4A29-A2BF-678B3DD0A700Q41444726-36E58E40-D4CD-498F-8C7C-CD661DA75199Q41968150-EA8A0FFF-86FC-4EA8-8570-64F6679803EDQ42168423-65B4E434-3DA7-42C1-9E99-37896D67486EQ42205403-6115977E-5C2B-4451-9741-6CEBA96026D3Q42415561-92C18E17-31BE-468A-8017-DE7531E36596Q43067863-8BAA93C1-D216-441C-BA76-71FFDBE297DAQ45869828-DA445396-2A23-4BE7-8C30-71A0DC256586Q47965414-4019DBA7-7AF3-4120-BF18-076895CCD7F0Q50227689-B08BCA71-AEDD-43D9-8FDA-03DDF0271392Q50740288-348D027C-4330-429D-8275-11911975D036
P2860
TRPV1 antagonists: the challenges for therapeutic targeting
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
TRPV1 antagonists: the challenges for therapeutic targeting
@ast
TRPV1 antagonists: the challenges for therapeutic targeting
@en
TRPV1 antagonists: the challenges for therapeutic targeting
@nl
type
label
TRPV1 antagonists: the challenges for therapeutic targeting
@ast
TRPV1 antagonists: the challenges for therapeutic targeting
@en
TRPV1 antagonists: the challenges for therapeutic targeting
@nl
prefLabel
TRPV1 antagonists: the challenges for therapeutic targeting
@ast
TRPV1 antagonists: the challenges for therapeutic targeting
@en
TRPV1 antagonists: the challenges for therapeutic targeting
@nl
P1476
TRPV1 antagonists: the challenges for therapeutic targeting
@en
P2093
Arpad Szallasi
Neelima Khairatkar-Joshi
P356
10.1016/J.MOLMED.2008.11.004
P407
P577
2009-01-01T00:00:00Z